Verona Pharma plc buy Wedbush
Start price
04.08.23
/
50%
€0.51
Target price
04.08.24
€27.18
Performance (%)
-
End price
05.08.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -1,42 % | 8,92 % | 7,31 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % | 36,65 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % | 46,60 % |
| iShares S&P 500 | 1,45 % | 10,91 % | 27,17 % |
Comments by Wedbush for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten